CHEBI:90875 - Synjardy

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name Synjardy
ChEBI ID CHEBI:90875
Definition A mixture composed of empagliflozin and metformin hydrochloride that is used for treatment of type II diabetes.
Stars This entity has been manually annotated by the ChEBI Team.
Roles Classification
Biological Role(s): sodium-glucose transport protein subtype 2 inhibitor
Any inhibitor that interferes with the action of sodium-glucose transport protein subtype 2.
Application(s): hypoglycemic agent
A drug which lowers the blood glucose level.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing Synjardy (CHEBI:90875) has part empagliflozin (CHEBI:82720)
Synjardy (CHEBI:90875) has part metformin hydrochloride (CHEBI:6802)
Synjardy (CHEBI:90875) has role hypoglycemic agent (CHEBI:35526)
Synjardy (CHEBI:90875) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273)
Synjardy (CHEBI:90875) is a mixture (CHEBI:60004)
Synonyms Sources
Empagliflozin - metformin mixt KEGG DRUG
Empagliflozin and metformin HCl ChemIDplus
Empagliflozin and metformin hydrochloride ChemIDplus
Empagliflozin mixture with metformin hydrochloride ChemIDplus
empagliflozin/metformin ChEBI
metformin hydrochloride and empagliflozin ChEBI
metformin hydrochloride mixture with empagliflozin ChEBI
Metformin/Empagliflozin ChemIDplus
Brand Name Source
Synjardy KEGG DRUG
Manual Xref Database
D10752 KEGG DRUG
View more database links
Citations Waiting for Citations Types Sources
26535019 PubMed citation Europe PMC
26670554 PubMed citation Europe PMC
Last Modified
08 January 2016
General Comment
2016-01-08 The mixture has a ChemIDplus registry number of S900006750 (for details see: http://chem.sis.nlm.nih.gov/chemidplus/sid/startswith/s900006750).